Document is current
Any future updates will be listed below
-
Authors
Kies, Paige J.
Kim, Won-Jun
Fleming, Derek
Bozyel, Ibrahim
Holtegaard, Susan
Shrivastava, Shreya
Schwartz, Kaitlin
Schwieder, Stephanie
Beyenal, Haluk
Patel, Robin
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI091594, R01AI091594, R01AI091594, R01AI091594, R01AI091594, R01AI091594, R01AI091594, R01AI091594, R01AI091594, R01AI091594)
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 24 September 2025
First Online: 30 October 2025
Declarations
:
: Dr. Patel reports grants from MicuRx Pharmaceuticals and bioMérieux. Dr. Patel is a consultant to PhAST, DEEPULL DIAGNOSTICS, S.L., Nostics, HealthTrackRx, bioMérieux and CARB-X. In addition, Dr. Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication, a patent on PET imaging of bacterial infection with a PET probe filed, and a patent on an anti-biofilm substance issued. Dr. Patel receives honoraria from Up-to-Date and the Infectious Diseases Board Review Course. Dr. Beyenal holds a patent (US20180207301A1), “Electrochemical reduction or prevention of infections”, which refers to the electrochemical scaffold upon which the current design of e-bandaged employed in this study is based. All other authors have no conflict of interest.
: This clinical trial was conducted in accordance with the Declaration of Helsinki and has been approved by the Mayo Clinic IRB under protocol #23-003805. All participants gave informed consent to be enrolled in the study and to the publication of study results.
